12-[2-(Benzyl-propyl-amino)-ethyl]-2,3-dimethoxy-12H-8,10-dioxa-6,12-diaza-cyclopenta[b]chrysen-13-one

ID: ALA192202

PubChem CID: 11341456

Max Phase: Preclinical

Molecular Formula: C31H31N3O5

Molecular Weight: 525.61

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(=O)n(CCN(Cc3ccccc3)C(C)C)c3c4cc5c(cc4ncc3c2cc1OC)OCO5

Standard InChI:  InChI=1S/C31H31N3O5/c1-19(2)33(17-20-8-6-5-7-9-20)10-11-34-30-23-14-28-29(39-18-38-28)15-25(23)32-16-24(30)21-12-26(36-3)27(37-4)13-22(21)31(34)35/h5-9,12-16,19H,10-11,17-18H2,1-4H3

Standard InChI Key:  XYRZFYWJJYQIPV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 44  0  0  0  0  0  0  0  0999 V2000
   -0.3833    0.1333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833    0.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1083   -0.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1083    1.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8208    0.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8208    0.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292    1.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292    2.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417    0.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5333    1.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5333   -0.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3958    2.6125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1083    2.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417    2.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542    1.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542    2.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2458    0.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2458    0.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -1.5292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1083   -1.1042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5417    1.1208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5417    2.4583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0292    1.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9708    1.3833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9708   -0.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4667   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4667   -2.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -3.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6833    0.9708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6833    0.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1917   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4667   -4.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1917   -3.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  2  1  0
  8  7  2  0
  9  7  1  0
 10  5  2  0
 11  6  2  0
 12  8  1  0
 13  4  1  0
 14  1  1  0
 15  8  1  0
 16  9  2  0
 17 16  1  0
 18 19  2  0
 19 11  1  0
 20 24  1  0
 21  3  2  0
 22 16  1  0
 23 17  1  0
 24 14  1  0
 25 22  1  0
 26 20  1  0
 27 20  1  0
 28 18  1  0
 29 19  1  0
 30 26  1  0
 31 27  1  0
 32 27  1  0
 33 30  1  0
 34 30  2  0
 35 28  1  0
 36 29  1  0
 37 33  2  0
 38 34  1  0
 39 38  2  0
  5  4  1  0
 12 13  2  0
 18 10  1  0
 17 15  2  0
 25 23  1  0
 39 37  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 525.61Molecular Weight (Monoisotopic): 525.2264AlogP: 5.36#Rotatable Bonds: 8
Polar Surface Area: 75.05Molecular Species: BASEHBA: 8HBD:
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.63CX LogP: 4.59CX LogD: 3.33
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.25Np Likeness Score: -0.66

References

1. Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ..  (2005)  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.,  48  (3): [PMID:15689163] [10.1021/jm049447z]
2. Zhou W, Dai Z, Chen Y, Yuan Z.  (2013)  Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues,  22  (1): [10.1007/s00044-012-0034-x]

Source